338 related articles for article (PubMed ID: 4205888)
21. Rifampicin and ethambutol in the treatment of drug resistant and far advanced pulmonary tuberculosis (with a note on capreomycin).
Pines A; Raafat H; Siddiqui GM
J Ir Med Assoc; 1970 Mar; 63(393):82-5. PubMed ID: 4984340
[No Abstract] [Full Text] [Related]
22. Bacteriologic basis of short-course chemotherapy for tuberculosis.
Grosset J
Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
[No Abstract] [Full Text] [Related]
23. [Rifampicin combined with ethambutol and other antitubercular drugs in the treatment of patients with pulmonary tuberculosis. Early results. I. Bacteriological evaluation].
Masztalerz J
Pneumonol Pol; 1976; 44(1):55-60. PubMed ID: 821043
[No Abstract] [Full Text] [Related]
24. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
Kam KM; Yip CW
Int J Tuberc Lung Dis; 2001 Sep; 5(9):815-23. PubMed ID: 11573892
[TBL] [Abstract][Full Text] [Related]
25. [Dynamics of the release of bacilli and the closing of caverns in newly identified tuberculosis patients undergoing different chemotherapeutic regimens].
Muratov VV; Pashkov IuN; Pospelov VV
Probl Tuberk; 1981 Dec; (12):30-4. PubMed ID: 6801646
[No Abstract] [Full Text] [Related]
26. [Clinical manifestations and treatment of respiratory organ tuberculosis in children caused by Mycobacterium bovis].
Niiazbekova KZh
Probl Tuberk; 1985; (4):28-31. PubMed ID: 3923470
[No Abstract] [Full Text] [Related]
27. [Short-term chemotherapy of pulmonary tuberculosis. Pilot study].
Poppe de Figueiredo F; Brito AA; Laborne Valle JH; Tavares PM; Trannin PL
Bull Int Union Tuberc; 1974; 49(1):411-7. PubMed ID: 4619561
[No Abstract] [Full Text] [Related]
28. Use of molecular techniques to distinguish between treatment failure and exogenous reinfection with Mycobacterium tuberculosis.
Krüüner A; Pehme L; Ghebremichael S; Koivula T; Hoffner SE; Mikelsaar M
Clin Infect Dis; 2002 Jul; 35(2):146-55. PubMed ID: 12087520
[TBL] [Abstract][Full Text] [Related]
29. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
[TBL] [Abstract][Full Text] [Related]
30. [Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy].
Freerksen E
Dtsch Med Wochenschr; 1970 Jan; 95(3):139-41. PubMed ID: 5411222
[No Abstract] [Full Text] [Related]
31. Viable Mycobacterium tuberculosis in sputum after pulmonary tuberculosis cure.
Ambreen A; Jamil M; Rahman MAU; Mustafa T
BMC Infect Dis; 2019 Oct; 19(1):923. PubMed ID: 31666021
[TBL] [Abstract][Full Text] [Related]
32. Drug-resistant tuberculosis in Taipei, 1996-1999.
Wang PD; Lin RS
Am J Infect Control; 2001 Feb; 29(1):41-7. PubMed ID: 11172317
[TBL] [Abstract][Full Text] [Related]
33. Tuberculosis and renal transplantation.
Zaragoza RM; Hernandez A; Treviño M; Diliz HS; Alvarez L
Transplant Proc; 1996 Dec; 28(6):3309. PubMed ID: 8962285
[No Abstract] [Full Text] [Related]
34. Primary isoniazid resistance in Mycobacterium bovis disease: a prospect of concern.
McLaughlin AM; Gibbons N; Fitzgibbon M; Power JT; Foley SC; Hayes JP; Rogers T; Keane J
Am J Respir Crit Care Med; 2012 Jul; 186(1):110-1. PubMed ID: 22753693
[No Abstract] [Full Text] [Related]
35. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
Ige OM; Bakare NA; Onadeko BO
Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469
[TBL] [Abstract][Full Text] [Related]
36. [Resistance of mycobacterial tuberculosis complex to the main antibacillary agent in Yaounde, Cameroon].
Bercion R; Kuaban C
Bull Soc Pathol Exot; 1998; 91(3):199-202. PubMed ID: 9773189
[TBL] [Abstract][Full Text] [Related]
37. Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months.
Trébucq A; Rieder HL
Int J Tuberc Lung Dis; 1998 Mar; 2(3):184-6. PubMed ID: 9526189
[No Abstract] [Full Text] [Related]
38. [Bacteriologic negation and anatomic development in pulmonary specimens after rifampicin treatment of less than 10 months (10 cases)].
Constans P; Parrot R; Coury C
Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):511-8. PubMed ID: 4994883
[No Abstract] [Full Text] [Related]
39. [Tuberculosis].
Bonnaud F; Zigani A
Rev Prat; 2002 Oct; 52(16):1809-20. PubMed ID: 12564174
[No Abstract] [Full Text] [Related]
40. [Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis].
Khudushina TA; Voloshina EP; Adamovich NV; Maslakova MG; Terekhova ND
Probl Tuberk Bolezn Legk; 2005; (12):37-9. PubMed ID: 16496762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
